Skip to main content

Advertisement

Log in

De novo posttransplant membranous nephropathy after COVID-19 vaccination 9 years after renal transplantation in a patient with polycystic kidney disease

  • Case Report
  • Published:
CEN Case Reports Aims and scope Submit manuscript

Abstract

A 63-year-old man with polycystic kidney disease underwent kidney transplantation from his wife. Nine years later, after the first and second doses of the COVID-19 vaccination, he developed proteinuria, hematuria, and elevated C-reactive protein. Kidney biopsy 7 months after the initial appearance of proteinuria showed immunoglobulin (Ig)-G granular stain, predominantly IgG1, and spike formation in the glomerular basement membrane. Electron microscopy revealed mainly subepithelial deposits, which corresponds to membranous nephropathy (MN) stage 3 of the Ehrenreich–Churg classification indicating chronic disease, but it also showed electron-dense deposits and endothelial damage. Because a kidney biopsy was performed 1 h after renal transplantation and a biopsy of the patient’s native kidney showed intact glomeruli, atypical de novo posttransplant membranous nephropathy (MN) was diagnosed, and a close relationship with COVID-19 vaccination was assumed. Clinicians should consider the involvement of COVID-19 vaccination in de novo posttransplant MN with unclear pathogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Leon J, Pérez-Sáez MJ, Batal I, Beck LH Jr, Rennke HG, Canaud G, Legendre C, Pascual J, Riella LV. Membranous nephropathy posttransplantation: an update of the pathophysiology and management. Transplantation. 2019;103(10):1990–2002.

    Article  CAS  PubMed  Google Scholar 

  2. Klomjit N, Alexander MP, Fervenza FC, Zoghby Z, Garg A, Hogan MC, Nasr SH, Minshar MA, Zand L. COVID-19 vaccination and glomerulonephritis. Kidney Int Rep. 2021;6(12):2969–78.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Ota Y, Kuroki R, Iwata M, Taira H, Matsuo S, Kamijo M, Muta K, Nishino T. Association between COVID-19 vaccination and relapse of glomerulonephritis. Clin Exp Nephrol. 2023;27(3):236–42.

    Article  CAS  PubMed  Google Scholar 

  4. Shakoor MT, Birkenbach MP, Lynch M. ANCA-associated vasculitis following Pfizer-BioNTech COVID-19 vaccine. Am J Kidney Dis. 2021;78(4):611–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Thammathiwat T, Chompuk L, Worawichawong S, Boonpucknavig V, Sirilak S, Pongcharoen S, Pichitsiri W, Kanjanabuch T. Membranous nephropathy following full-dose of inactivated SARS-CoV-2 virus vaccination: a case report and literature review. Vaccines (Basel). 2022;11(1):80.

    Article  PubMed  Google Scholar 

  6. Chavarot N, Padden M, Amrouche L, Malard S, Scemla A, Sberro-Soussan R, Léon J, Legendre C, Duong JP, Zuber J, Anglicheau D, Rabant M, Isnard P. De novo posttransplant membranous nephropathy following BNT162b2 mRNA COVID-19 vaccine in a kidney transplant recipient. Am J Transplant. 2022;22(12):3188–9.

    Article  CAS  PubMed  Google Scholar 

  7. Aydın MF, Yıldız A, Oruç A, Sezen M, Dilek K, Güllülü M, Yavuz M, Ersoy A. Relapse of primary membranous nephropathy after inactivated SARS-CoV-2 virus vaccination. Kidney Int. 2021;100(2):464–5.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Da Y, Goh GH, Khatri P. A case of membranous nephropathy following Pfizer-BioNTech mRNA vaccination against COVID-19. Kidney Int. 2021;100(4):938–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Gueguen L, Loheac C, Saidani N, Khatchatourian L. Membranous nephropathy following anti-COVID-19 mRNA vaccination. Kidney Int. 2021;100(5):1140–1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Nasr SH, Alexander MP, Cornell LD, Herrera LH, Fidler ME, Said SM, Zhang P, Larsen CP, Sethi S. Kidney biopsy findings in patients with COVID-19, kidney injury, and proteinuria. Am J Kidney Dis. 2021;77(3):465–8.

    Article  CAS  PubMed  Google Scholar 

  11. Nakagawa N, Maruyama S, Kashihara N, Narita I, Isaka Y. New-onset and relapse of nephrotic syndrome following COVID-19 vaccination: a questionnaire survey in Japan. Clin Exp Nephrol. 2022;26(9):909–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Matsuzaki K, Aoki R, Nihei Y, Suzuki H, Kihara M, Yokoo T, Kashihara N, Narita I, Suzuki Y. Gross hematuria after SARS-CoV-2 vaccination: questionnaire survey in Japan. Clin Exp Nephrol. 2022;26(4):316–22.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Dr. Fukuda: study concept and design and data acquisition; Drs. Sawa, Suwabe: data analysis and interpretation; Drs. Ikuma, Mizuno, Oba, Sekine, Hasegawa, Yamanouchi: study supervision; Drs. Kono, Kinowaki, Ohashi, Yamaguchi: histological analysis; Drs. Nakamura, Miki, Yokoyama, Ishii: surgery; Dr. Ubara: critical revision of the manuscript for important intellectual content.

Corresponding authors

Correspondence to Miruzato Fukuda or Yoshifumi Ubara.

Ethics declarations

Conflict of interest

The authors have no competing financial interests or conflicts of interest to declare.

Ethical approval

This investigation was performed in accordance with the Declaration of Helsinki. The patient gave written informed consent for this case report to be published.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fukuda, M., Yokoyama, T., Miki, K. et al. De novo posttransplant membranous nephropathy after COVID-19 vaccination 9 years after renal transplantation in a patient with polycystic kidney disease. CEN Case Rep (2024). https://doi.org/10.1007/s13730-024-00864-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13730-024-00864-4

Keywords

Navigation